Lyme study pulled: could pulsed antibiotics have ended chronic symptoms?
NCT ID NCT06785402
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 28 times
Summary
This study aimed to see if giving the antibiotic ceftriaxone every 5 days for 6 weeks could kill lingering Lyme bacteria in people with Post-Treatment Lyme Disease Syndrome (PTLDS). It planned to enroll adults aged 18-75 with PTLDS and compare the drug to a placebo. However, the study was withdrawn before any participants were enrolled, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST-TREATMENT LYME DISEASE SYNDROME are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hackensack University Medical Center
Hackensack, New Jersey, 07601, United States
Conditions
Explore the condition pages connected to this study.